SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently experiencing high levels of community discourse, with traders heavily debating its short-term price action and potential for a significant squeeze. Many participants are actively layering large buy orders to combat short positions, while others remain skeptical of the project's long-term utility and historical performance compared to newer meme coins.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a new federal grant for quantum technology and high-level government interest in the sector, sparking debate over whether these catalysts justify current valuations or if the stock is primed for a correction. While some in the community see the recent policy support as a long-term inflection point, others remain skeptical, citing continued executive selling and concerns over the company's path to profitability compared to industry peers.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

The GraniteShares 2x Long MU Daily ETF is seeing intense activity as traders capitalize on the extreme volatility of its underlying asset, Micron Technology. Community discussion is heavily focused on managing leveraged positions through strategic scaling and volume-sensitive execution to avoid institutional traps and decay during rapid price swings.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors weigh potential impacts of upcoming clinical trial catalysts and continued commercial growth against historical legal volatility. The community remains focused on the company's path to profitability and is actively monitoring institutional accumulation patterns despite recent market-wide biotech fluctuations.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors focus on the pivotal NEXICART-2 trial for NXC-201, with excitement building around top-line data and the potential for a breakthrough in treating relapsed/refractory AL amyloidosis. The community is actively discussing a recent leadership reset and the company's strong institutional backing, fueling speculation about near-term clinical catalysts and long-term strategic value.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community debate over its institutional ownership and the long-term impact of reimbursement shifts, with investors actively tracking legislative efforts like KCAPA for relief. While some market participants express frustration over price volatility and perceived lack of management communication, others remain focused on the company's revenue growth, share buyback potential, and the strategic expansion of its anti-infective platform.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is currently in the spotlight as investors weigh the company's aggressive expansion into AI infrastructure against concerns regarding dividend sustainability and elevated debt levels. The community is actively debating the stock's long-term value, with many viewing the recent price pullback as an attractive buying opportunity while others remain cautious about potential dividend policy changes.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is capturing investor attention as the company navigates strategic restructuring and board appointments following recent activist stake involvement. Community discussions are centered on ongoing innovation in medical robotics and diabetes tech, alongside speculation about potential long-term price appreciation supported by dividend performance.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors weigh persistent institutional inflow against broader market volatility and macroeconomic uncertainty surrounding the digital asset sector. Community discourse remains heavily focused on the ongoing debate between Bitcoin's long-term value proposition and the immediate impact of institutional adoption, mining economics, and potential regulatory shifts.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as investors debate whether the current price action represents a classic accumulation phase or an abandoned project, with the community sharply divided between long-term holders adding to positions and critics citing a lack of clear utility or communication. Discussions are currently dominated by intense skepticism regarding the team's focus on ecosystem expansion versus recent price underperformance, alongside technical debates about support levels and market-wide volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Sentiment